Compound Kills Persistent and Drug-Resistant Tuberculosis
Monday, June 17, 2013 - 15:30
in Health & Medicine
An international team led by scientists at The Scripps Research Institute, the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.